DK1531839T3 - Beroligende fugle-feromoner til nedsættelse af stress, angst og aggressivitet - Google Patents

Beroligende fugle-feromoner til nedsættelse af stress, angst og aggressivitet

Info

Publication number
DK1531839T3
DK1531839T3 DK03760696.9T DK03760696T DK1531839T3 DK 1531839 T3 DK1531839 T3 DK 1531839T3 DK 03760696 T DK03760696 T DK 03760696T DK 1531839 T3 DK1531839 T3 DK 1531839T3
Authority
DK
Denmark
Prior art keywords
aggressiveness
anxiety
pheromones
soothing
bird
Prior art date
Application number
DK03760696.9T
Other languages
English (en)
Inventor
Patrick Pageat
Original Assignee
Fideline
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fideline filed Critical Fideline
Application granted granted Critical
Publication of DK1531839T3 publication Critical patent/DK1531839T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Feed For Specific Animals (AREA)
DK03760696.9T 2002-06-19 2003-06-19 Beroligende fugle-feromoner til nedsættelse af stress, angst og aggressivitet DK1531839T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38976802P 2002-06-19 2002-06-19
EP02291533 2002-06-19
PCT/EP2003/007144 WO2004000336A1 (en) 2002-06-19 2003-06-19 Avian appeasing pheromones to decrease stress, anxiety and aggressiveness

Publications (1)

Publication Number Publication Date
DK1531839T3 true DK1531839T3 (da) 2010-09-13

Family

ID=42635094

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03760696.9T DK1531839T3 (da) 2002-06-19 2003-06-19 Beroligende fugle-feromoner til nedsættelse af stress, angst og aggressivitet

Country Status (12)

Country Link
EP (1) EP1531839B1 (da)
JP (1) JP4863619B2 (da)
CN (1) CN100508968C (da)
AT (1) ATE468123T1 (da)
AU (1) AU2003246372B8 (da)
BR (1) BRPI0311934B1 (da)
CA (1) CA2490681C (da)
DK (1) DK1531839T3 (da)
ES (1) ES2345099T3 (da)
MX (1) MXPA04013005A (da)
PT (1) PT1531839E (da)
WO (1) WO2004000336A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3119410T (lt) * 2014-03-18 2022-08-25 Institut de Recherche en Semiochimie et Ethologie Appliquée Raminamasis feromonas katėms
WO2016131640A1 (en) * 2015-02-20 2016-08-25 Nestec S.A. Medium chain fatty acids and their triglycerides for treating anxiety
US9943480B2 (en) * 2015-11-03 2018-04-17 Wisconsin Alumni Research Foundation Compositions containing preen oil and methods of use thereof
BE1023693B1 (nl) * 2016-06-15 2017-06-16 Vervaeke-Belavi Nv Werkwijze voor het produceren van kuikens
US11529418B2 (en) 2017-12-22 2022-12-20 Ceva Sante Animale Temperature-controlled semiochemical composition diffusers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3039817B2 (ja) * 1990-09-28 2000-05-08 株式会社資生堂 シャンプー組成物
US5272134A (en) * 1992-03-24 1993-12-21 Erox Corporation Fragrance compositions and other compositions which contain human pheromones
FR2715069B1 (fr) * 1994-01-20 1996-04-05 Rene Laversanne Procédé pour améliorer la rémanence d'une odeur.
DE19511572C2 (de) * 1995-03-29 1998-02-26 Henkel Kgaa Niedrigviskose Trübungsmittelkonzentrate
DE19615777C2 (de) * 1996-04-20 1999-04-01 Henkel Kgaa Verwendung von Milchsäure-Milchsäureester-Mischungen
GB9720814D0 (en) * 1997-10-01 1997-12-03 Kiotech Limited Pheromone composition
EP0948963B1 (en) * 1998-01-21 2003-05-07 Fideline Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
US6054481A (en) * 1998-01-21 2000-04-25 Fideline Pig appeasing pheromones for enhancing weight gain in a mammal
BR9917806B1 (pt) * 1998-01-21 2013-06-18 composiÇço de feromona para tratamento de estresse ou ansiedade em mamÍferos, e soluÇço.
IL142910A0 (en) * 1998-11-02 2002-04-21 Triangle Pharmaceuticals Inc Combination therapy to treat hepatitis b virus

Also Published As

Publication number Publication date
PT1531839E (pt) 2010-07-21
AU2003246372B2 (en) 2008-11-27
WO2004000336A1 (en) 2003-12-31
JP2006508038A (ja) 2006-03-09
ATE468123T1 (de) 2010-06-15
ES2345099T3 (es) 2010-09-15
CA2490681A1 (en) 2003-12-31
BR0311934A (pt) 2005-04-05
EP1531839B1 (en) 2010-05-19
AU2003246372A1 (en) 2004-01-06
JP4863619B2 (ja) 2012-01-25
BRPI0311934B1 (pt) 2015-05-26
AU2003246372B8 (en) 2009-03-26
CA2490681C (en) 2012-01-24
CN1668318A (zh) 2005-09-14
MXPA04013005A (es) 2005-09-12
CN100508968C (zh) 2009-07-08
EP1531839A1 (en) 2005-05-25

Similar Documents

Publication Publication Date Title
DK1047415T3 (da) Pheromoner, der beroliger svin, til reduktion af stress, angst og aggressivitet
BRPI0515316A (pt) compostos de imidazoquinolina
UY29007A1 (es) Derivados de 2-carbamida-4-feniltiazol, su preparacinn, y su aplicacinn en terapcutica
AR047529A1 (es) Compuestos de quinolina sustituidos
CY1116700T1 (el) Παρασκευη συνθετικου χολικου οξεος
GT200500363A (es) 3-amino-pirazol [3,4b] piridinas con inhibidores de proteintirosinquinasas, su preparacion y uso como medicamento.
RS51271B (sr) Čvrsta farmaceutska kompozicija koja sadrži donepezil hidrohlorid
ATE396697T1 (de) Zuckerlacton enthaltende zusammensetzung zur haarbehandlung
BRPI0510526A (pt) formulações lìquidas estabilizadas de interferon
RS52671B (en) IMPROVED TESTOSTERON GEL AND USE PROCEDURE
CL2012002705A1 (es) Composicion farmaceutica que comprende: a) 0,1-20% de ropivacaina,bupivacaina o levobupivacaina, b) 15 a 70% en peso de un monoglicerido de acido graso de cadena larga o sus mezclas, c) 5 a 60% de un acido graso libre saturado o instaurado de cadena larga y d)menos de 30% de agua; uso para reducir el dolor.
DE602006011127D1 (de) Fettsäure-benzenediol-derivate sowie herstellungs- und verwendungsverfahren dafür
DE502007004498D1 (de) O/w emulsion zur pflege der hand
DK1531839T3 (da) Beroligende fugle-feromoner til nedsættelse af stress, angst og aggressivitet
DE60303312D1 (de) Thrombinspaltbare faktor-x-analoga
DE60305068D1 (de) Behandlung von mastalgie mit4-hydroxy-tamoxifen
DK1735005T3 (da) Fremgangsmåde til indkapsling af oralt indtagne materialer til ændring af fordøjelsesstedet, virkningsstedet eller stabiliteten
ME00249B (me) Oralne formulacije kladribina
TN2010000058A1 (fr) Composition therapeutique aromatisee a base d'argile
DE60219148D1 (de) Pharmazeutische Zusammensetzung zur Verhinderung der Entwicklung und Progression von mykotischen Hautoberflächenerkrankungen
ATE304374T1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
DE60332635D1 (de) Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität
CY1107277T1 (el) Βενζισοξαζολες
ATE374811T1 (de) Hühner-astrovirus typ 2
NO20023841L (no) Anvendelse av glukokortikoidreseptorantagonister for forebygging og behandling av sykdommer av reproduksjonssystemet hos menn